Skip to main content
Fig. 2 | BMC Public Health

Fig. 2

From: Impact of national-scale targeted point-of-care symptomatic lateral flow testing on trends in COVID-19 infections, hospitalisations and deaths during the second epidemic wave in Austria (REAP3)

Fig. 2

A-F: Comparison of six indicators between study cohorts with high, medium and low POC-LFT. A: Monthly ratio (number of people/100,000 inhabitants) of the sum of combined reactive and non-reactive POC-LFT. B: Monthly ratio (number of people/100,000 inhabitants) of people with a positive PCR test result. C: Monthly ratio (number of people/100,000 inhabitants) of hospital admissions (or hospitalizations) related to COVID-19. D: Monthly ratio (number of people/100,000 inhabitants) of deaths related to COVID-19 from October 01 to December 31, 2020, for each of the high, medium and low POCLFT district cohorts. E: Monthly proportions of people with reactive POCLFT result to the total number of POC-LFTs received per POC-LFT cohort. F: Monthly proportions of people with reactive POC-LFT result to the total number of patients testing PCR positive per POC-LFT cohort. POC-LFT: point-of-care lateral flow antigen test

Back to article page